🔴 Website 👉 https://u-s-news.com/
Telegram 👉 https://t.me/usnewscom_channel
The National Health Service (NHS) has rolled out a new ‘super-jab’ that thousands of patients will receive monthly.
NHS claims the ‘super-jab’ can treat 15 types of cancer.
“Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection,” NHS stated.
“The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or monthly treatment in 5 minutes instead of up to an hour via an IV drip,” it added.
Thousands of patients in England are set to benefit from a new five-minute ‘super-jab’ that can treat 15 types of cancer that will ‘transform lives’. The NHS is the first health service in Europe to offer the injection, which will save around a year’s worth of treatment,… pic.twitter.com/tvrU5kzgXr
— “Sudden And Unexpected” (@toobaffled) May 2, 2025
Per NHS:
The roll-out will save over a year’s worth of treatment time for patients and NHS teams annually – enabling patients to spend less time in hospital while freeing up staff capacity to deliver more appointments and treatments.
The new jab can be used to treat 15 cancer types, including skin cancer, bladder, and oesophagus, and it is estimated around 1,200 patients in England per month could benefit.
This follows approval from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) today.
In clinical trials, patients were highly satisfied with the under-the-skin injection, which takes 3-5 minutes to administer, and preferred it to the IV form of the drug which takes 30 to 60 minutes every 2 weeks or four weeks, depending on the cancer type.
Around 2 in 5 patients who currently receive IV nivolumab, which is one of the most widely used cancer treatments, should be eligible for the new jab.
NHS staff administering the jab could save around 1,000 hours of treatment time for patients and clinicians every month – the equivalent of more than 1 full year of time annually.
Most eligible new patients are also expected to begin on the injectable form of nivolumab.
NHS cancer services will now be preparing to treat the first patients with the new treatment next month when supplies of the product are received in the UK, helping to free up valuable resources in nursing and pharmacy teams, as well as helping with capacity demands in cancer day units, where the drug is currently administered.
This is the latest in a series of NHS cancer treatment innovations introduced to save patients time and improve access, including the rollout of new injections for breast cancer, multiple sclerosis, and blood disorders.
The NHS is introducing a new five-minute injection for 15 types of cancer, including skin, bladder and oesophageal.
NHS staff administering the jab could save around 1,000 hours of treatment time for patients and clinicians every month.
➡️ https://t.co/gMCtLD3vrZ pic.twitter.com/6iUazTT1jF
— NHS England (@NHSEngland) April 30, 2025
WATCH:
The United Kingdom’s National Health Service, the NHS, has rolled out a super jab that can treat up to 15 types of cancers, drastically cutting down treatment time from an hour to just 5 minutes@MollyGambhir reports pic.twitter.com/k3Bwvzjb9Q
— WION (@WIONews) May 1, 2025
Daily Mail reports:
It comes amid a disturbing rise in cancers including skin and bowel in the under 50s, which has baffled doctors around the globe.
Professor Peter Johnson, NHS England National Clinical Director for Cancer, said: ‘Immunotherapy has already been a huge step forward for many NHS patients with cancer, and being able to offer it as an injection in minutes means we can make the process far more convenient.
‘This treatment is used for 15 different types of the disease, so it will free up thousands of valuable clinicians’ time every year, allowing teams to treat even more patients and helping hospital capacity.
‘And this is just the latest development in the NHS’s ongoing commitment to provide patients with the latest cancer therapies and treatment options that truly transform lives.’
Ashley Dalton, the public health minister who announced earlier this year that she had been diagnosed with breast cancer for a second time, added: ‘Britain is a hotbed of innovation, masterminding the newest tech and medical inventions to help people navigating illness.
‘A new jab that fastens up cancer treatment is a prime example of this, so it’s fantastic to see cancer patients in England will be among the first in Europe to benefit.